LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 54

Search options

  1. Article ; Online: Fecal calprotectin levels in patients with non-celiac wheat sensitivity: a proof of concept.

    Seidita, Aurelio / Giuliano, Alessandra / Soresi, Maurizio / Chiavetta, Marta / Nardi, Emilio / Mogavero, Giuseppe / Giannone, Giulio / Carroccio, Antonio / Mansueto, Pasquale

    Internal and emergency medicine

    2024  

    Abstract: Some data suggest the existence of intestinal inflammation in patients with non-celiac wheat sensitivity (NCWS). We aimed to verify whether fecal calprotectin (FCP), a marker of intestinal inflammation, could be used to confirm this inflammatory status ... ...

    Abstract Some data suggest the existence of intestinal inflammation in patients with non-celiac wheat sensitivity (NCWS). We aimed to verify whether fecal calprotectin (FCP), a marker of intestinal inflammation, could be used to confirm this inflammatory status and to test its diagnostic performance in differentiating NCWS from irritable bowel syndrome/functional dyspepsia (IBS/FD). We conducted a multicenter study, comparing NCWS patients, diagnosed by a double-blind placebo-controlled wheat challenge, with IBS/FD subjects. In the retrospective phase, FCP values were analyzed to define the prevalence of its positivity and its role as a NCWS diagnostic biomarker. In the prospective phase we tested the effects of a strict 6-month wheat-free diet (WFD) on FCP values. 31.3% (n = 63/201) of NCWS patients had above normal FCP values (NCWS FCP +), whereas all IBS/FD patients proved negative (P = 0.0001). FCP using a cut-off value > 41 µg/g showed a 58.6% sensitivity and a 98.0% specificity (AUC 0.755, 95% C.I. 0.702-0.837) in distinguishing NCWS from IBS/FD patients. Of the 63 NCWS FCP+, 65.1% had negative FCP values after ≥ 6 months of WFD, with a significant reduction in FCP values (P < 0.0001). All NCWS FCP- subjects still preserved negative FCP values after ≥ 6 months of WFD. Our study showed that FCP can be a useful but supplementary diagnostic marker for differentiating between NCWS and IBS/FD. Strict WFD adherence reduced FCP values, normalizing them in 65.1% of NCWS FCP + subjects. These data suggest the existence of two NCWS subgroups: NCWS FCP + characterized by a probable predominantly inflammatory/immunologic pattern and NCWS FCP- featuring non-immuno-mediated etiopathogenetic mechanisms. (Registration number NCT01762579).
    Language English
    Publishing date 2024-04-12
    Publishing country Italy
    Document type Journal Article
    ZDB-ID 2454173-4
    ISSN 1970-9366 ; 1828-0447
    ISSN (online) 1970-9366
    ISSN 1828-0447
    DOI 10.1007/s11739-024-03595-7
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Left ventricular hypertrophy in chronic kidney disease: A diagnostic criteria comparison

    Nardi, Emilio / Mulè, Giuseppe / Giammanco, Antonina / Mattina, Alessandro / Geraci, Giulio / Nardi, Chiara / Averna, Maurizio

    The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University Nutrition, metabolism, and cardiovascular diseases. 2021 Jan. 04, v. 31, no. 1

    2021  

    Abstract: CKD patients have a high prevalence of LVH and this leads to an increase of cardiovascular risk. The aim of this study was to assess the prevalence of left ventricular hypertrophy (LVH) and left ventricular geometry in a group of 293 hypertensive ... ...

    Abstract CKD patients have a high prevalence of LVH and this leads to an increase of cardiovascular risk. The aim of this study was to assess the prevalence of left ventricular hypertrophy (LVH) and left ventricular geometry in a group of 293 hypertensive patients with stage 2–5 chronic kidney disease (CKD), compared with 289 essential hypertensive patients with normal renal function.All patients underwent echocardiographic examination. Patients on stage 1 CKD, dialysis treatment, or with cardiovascular diseases were excluded. LVH was observed in 62.8% of patients with CKD and in 51.9% of essential hypertensive patients (P < 0.0001). We found increasingly higher left ventricular diameters, thicknesses, and mass from stage 2–5 CKD. Distribution of concentric and eccentric LVH was not very different between the two groups. However, after introducing mixed hypertrophy, the difference between the two groups group was disclosed (P = 0.027). Multiple regression analysis confirmed that the association between renal function and left ventricular mass (β −0.287; P < 0.0001) was independent by potential confounders. Diastolic function was significantly worse in patients with CKD, especially in more advanced stages.Our study confirms that LVH is highly prevalent in patients with CKD, especially by using the most recent cut off; in this population, LVH is often characterized by the simultaneous increase of wall thicknesses and diameters with negative effects on diastolic function.
    Keywords cardiovascular diseases ; dialysis ; diameter ; echocardiography ; geometry ; hypertrophy ; kidney diseases ; mass ; metabolism ; nutrition ; patients ; population ; prevalence ; regression analysis ; renal function ; risk
    Language English
    Dates of publication 2021-0104
    Size p. 137-144.
    Publishing place Elsevier B.V.
    Document type Article
    Note NAL-light
    ZDB-ID 1067704-5
    ISSN 0939-4753
    ISSN 0939-4753
    DOI 10.1016/j.numecd.2020.08.028
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  3. Article ; Online: Hyperuricemia and high blood pressure at rest and during exercise: Guilty or innocent? The jury is still out.

    Mulè, Giuseppe / Nardi, Emilio / Lattuca, Luigi / Cottone, Santina

    Journal of clinical hypertension (Greenwich, Conn.)

    2018  Volume 20, Issue 3, Page(s) 557–559

    MeSH term(s) Blood Pressure ; Guilt ; Humans ; Hypertension ; Hyperuricemia ; Male ; Uric Acid
    Chemical Substances Uric Acid (268B43MJ25)
    Language English
    Publishing date 2018-02-19
    Publishing country United States
    Document type Journal Article ; Comment
    ZDB-ID 2077222-1
    ISSN 1751-7176 ; 1524-6175
    ISSN (online) 1751-7176
    ISSN 1524-6175
    DOI 10.1111/jch.13227
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: The nephroprotective effect of sacubitril/valsartan in heart failure: insights from the real-life clinical setting.

    Mulè, Giuseppe / Sorce, Alessandra / Nardi, Emilio / Geraci, Giulio / Cottone, Santina

    Internal and emergency medicine

    2019  Volume 14, Issue 8, Page(s) 1205–1208

    MeSH term(s) Aminobutyrates ; Drug Combinations ; Follow-Up Studies ; Heart Failure ; Humans ; Life ; Tetrazoles ; Valsartan
    Chemical Substances Aminobutyrates ; Drug Combinations ; Tetrazoles ; Valsartan (80M03YXJ7I) ; sacubitril and valsartan sodium hydrate drug combination (WB8FT61183)
    Language English
    Publishing date 2019-07-15
    Publishing country Italy
    Document type Journal Article ; Comment
    ZDB-ID 2454173-4
    ISSN 1970-9366 ; 1828-0447
    ISSN (online) 1970-9366
    ISSN 1828-0447
    DOI 10.1007/s11739-019-02149-6
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Left ventricular hypertrophy in chronic kidney disease: A diagnostic criteria comparison.

    Nardi, Emilio / Mulè, Giuseppe / Giammanco, Antonina / Mattina, Alessandro / Geraci, Giulio / Nardi, Chiara / Averna, Maurizio

    Nutrition, metabolism, and cardiovascular diseases : NMCD

    2020  Volume 31, Issue 1, Page(s) 137–144

    Abstract: Background and aims: CKD patients have a high prevalence of LVH and this leads to an increase of cardiovascular risk. The aim of this study was to assess the prevalence of left ventricular hypertrophy (LVH) and left ventricular geometry in a group of ... ...

    Abstract Background and aims: CKD patients have a high prevalence of LVH and this leads to an increase of cardiovascular risk. The aim of this study was to assess the prevalence of left ventricular hypertrophy (LVH) and left ventricular geometry in a group of 293 hypertensive patients with stage 2-5 chronic kidney disease (CKD), compared with 289 essential hypertensive patients with normal renal function.
    Methods and results: All patients underwent echocardiographic examination. Patients on stage 1 CKD, dialysis treatment, or with cardiovascular diseases were excluded. LVH was observed in 62.8% of patients with CKD and in 51.9% of essential hypertensive patients (P < 0.0001). We found increasingly higher left ventricular diameters, thicknesses, and mass from stage 2-5 CKD. Distribution of concentric and eccentric LVH was not very different between the two groups. However, after introducing mixed hypertrophy, the difference between the two groups group was disclosed (P = 0.027). Multiple regression analysis confirmed that the association between renal function and left ventricular mass (β -0.287; P < 0.0001) was independent by potential confounders. Diastolic function was significantly worse in patients with CKD, especially in more advanced stages.
    Conclusion: Our study confirms that LVH is highly prevalent in patients with CKD, especially by using the most recent cut off; in this population, LVH is often characterized by the simultaneous increase of wall thicknesses and diameters with negative effects on diastolic function.
    MeSH term(s) Adult ; Aged ; Blood Pressure ; Cross-Sectional Studies ; Essential Hypertension/diagnosis ; Essential Hypertension/epidemiology ; Essential Hypertension/physiopathology ; Female ; Heart Disease Risk Factors ; Humans ; Hypertension/diagnosis ; Hypertension/epidemiology ; Hypertension/physiopathology ; Hypertrophy, Left Ventricular/diagnostic imaging ; Hypertrophy, Left Ventricular/epidemiology ; Hypertrophy, Left Ventricular/physiopathology ; Italy/epidemiology ; Male ; Middle Aged ; Prevalence ; Renal Insufficiency, Chronic/diagnosis ; Renal Insufficiency, Chronic/epidemiology ; Renal Insufficiency, Chronic/physiopathology ; Risk Assessment ; Ventricular Function, Left ; Ventricular Remodeling ; Young Adult
    Language English
    Publishing date 2020-09-12
    Publishing country Netherlands
    Document type Comparative Study ; Journal Article
    ZDB-ID 1067704-5
    ISSN 1590-3729 ; 0939-4753
    ISSN (online) 1590-3729
    ISSN 0939-4753
    DOI 10.1016/j.numecd.2020.08.028
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Differences in Cardiac Structure and Function Between Black and White Patients: Another Step in the Evaluation of Cardiovascular Risk in Chronic Kidney Disease.

    Nardi, Emilio / Mulè, Giuseppe / Nardi, Chiara / Averna, Maurizio

    American journal of hypertension

    2017  Volume 30, Issue 8, Page(s) 770–771

    MeSH term(s) Cardiovascular Diseases ; Cohort Studies ; European Continental Ancestry Group ; Humans ; Renal Insufficiency, Chronic ; Risk Factors
    Language English
    Publishing date 2017-06-23
    Publishing country United States
    Document type Journal Article ; Comment
    ZDB-ID 639383-4
    ISSN 1941-7225 ; 1879-1905 ; 0895-7061
    ISSN (online) 1941-7225 ; 1879-1905
    ISSN 0895-7061
    DOI 10.1093/ajh/hpx093
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Statin-induced autoimmune myositis: a proposal of an "experience-based" diagnostic algorithm from the analysis of 69 patients.

    Gagliardo, Carola Maria / Noto, Davide / Giammanco, Antonina / Maltese, Silvia / Vecchio, Luca / Lavatura, Giuseppe / Cacciatore, Valentina / Barbagallo, Carlo Maria / Ganci, Antonina / Nardi, Emilio / Ciaccio, Marcello / Lo Presti, Rosalia / Cefalù, Angelo Baldassare / Averna, Maurizio

    Internal and emergency medicine

    2023  Volume 18, Issue 4, Page(s) 1095–1107

    Abstract: Statin-induced autoimmune myositis (SIAM) represents a rare clinical entity that can be triggered by prolonged statin treatment. Its pathogenetic substrate consists of an autoimmune-mediated mechanism, evidenced by the detection of antibodies directed ... ...

    Abstract Statin-induced autoimmune myositis (SIAM) represents a rare clinical entity that can be triggered by prolonged statin treatment. Its pathogenetic substrate consists of an autoimmune-mediated mechanism, evidenced by the detection of antibodies directed against the 3-hydroxy-3-methylglutaryl-coenzyme A reductase (anti-HMGCR Ab), the target enzyme of statin therapies. To facilitate the diagnosis of nuanced SIAM clinical cases, the present study proposes an "experience-based" diagnostic algorithm for SIAM. We have analyzed the clinical data of 69 patients diagnosed with SIAM. Sixty-seven patients have been collected from the 55 available and complete case records regarding SIAM in the literature; the other 2 patients represent our direct clinical experience and their case records have been detailed. From the analysis of the clinical features of 69 patients, we have constructed the diagnostic algorithm, which starts from the recognition of suggestive symptoms of SIAM. Further steps provide for CK values dosage, musculoskeletal MR, EMG/ENG of upper-lower limbs and, Anti-HMGCR Ab testing and, where possible, the muscle biopsy. A global evaluation of the collected clinical features may suggest a more severe disease in female patients. Atorvastatin proved to be the most used hypolipidemic therapy.
    MeSH term(s) Humans ; Female ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects ; Autoantibodies/adverse effects ; Myositis/chemically induced ; Myositis/diagnosis ; Autoimmune Diseases/diagnosis ; Autoimmune Diseases/drug therapy ; Algorithms
    Chemical Substances Hydroxymethylglutaryl-CoA Reductase Inhibitors ; Autoantibodies
    Language English
    Publishing date 2023-05-05
    Publishing country Italy
    Document type Journal Article
    ZDB-ID 2454173-4
    ISSN 1970-9366 ; 1828-0447
    ISSN (online) 1970-9366
    ISSN 1828-0447
    DOI 10.1007/s11739-023-03278-9
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Diabetes and aortic root dimension: A controversial subject.

    Nardi, Emilio / Mulè, Giuseppe / Nardi, Chiara / Geraci, Giulio / Averna, Maurizio

    International journal of cardiology

    2018  Volume 264, Page(s) 190

    MeSH term(s) Aorta ; Aortic Valve ; Diabetes Mellitus ; Humans
    Language English
    Publishing date 2018-05-19
    Publishing country Netherlands
    Document type Letter ; Comment
    ZDB-ID 779519-1
    ISSN 1874-1754 ; 0167-5273
    ISSN (online) 1874-1754
    ISSN 0167-5273
    DOI 10.1016/j.ijcard.2018.03.071
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Lipoprotein Abnormalities in Chronic Kidney Disease and Renal Transplantation.

    Barbagallo, Carlo Maria / Cefalù, Angelo Baldassare / Giammanco, Antonina / Noto, Davide / Caldarella, Rosalia / Ciaccio, Marcello / Averna, Maurizio Rocco / Nardi, Emilio

    Life (Basel, Switzerland)

    2021  Volume 11, Issue 4

    Abstract: Chronic kidney disease (CKD) is one of the most important risk factors for cardiovascular disease (CVD). Despite the kidney having no direct implications for lipoproteins metabolism, advanced CKD dyslipidemia is usually present in patients with CKD, and ... ...

    Abstract Chronic kidney disease (CKD) is one of the most important risk factors for cardiovascular disease (CVD). Despite the kidney having no direct implications for lipoproteins metabolism, advanced CKD dyslipidemia is usually present in patients with CKD, and the frequent lipid and lipoprotein alterations occurring in these patients play a role of primary importance in the development of CVD. Although hypertriglyceridemia is the main disorder, a number of lipoprotein abnormalities occur in these patients. Different enzymes pathways and proteins involved in lipoprotein metabolism are impaired in CKD. In addition, treatment of uremia may modify the expression of lipoprotein pattern as well as determine acute changes. In renal transplantation recipients, the main lipid alteration is hypercholesterolemia, while hypertriglyceridemia is less pronounced. In this review we have analyzed lipid and lipoprotein disturbances in CKD and also their relationship with progression of renal disease. Hypolipidemic treatments may also change the natural history of CVD in CKD patients and may represent important strategies in the management of CKD patients.
    Language English
    Publishing date 2021-04-05
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2662250-6
    ISSN 2075-1729
    ISSN 2075-1729
    DOI 10.3390/life11040315
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: Hyperalphalipoproteinemia and Beyond: The Role of HDL in Cardiovascular Diseases.

    Giammanco, Antonina / Noto, Davide / Barbagallo, Carlo Maria / Nardi, Emilio / Caldarella, Rosalia / Ciaccio, Marcello / Averna, Maurizio Rocco / Cefalù, Angelo Baldassare

    Life (Basel, Switzerland)

    2021  Volume 11, Issue 6

    Abstract: Hyperalphalipoproteinemia (HALP) is a lipid disorder characterized by elevated plasma high-density lipoprotein cholesterol (HDL-C) levels above the 90th percentile of the distribution of HDL-C values in the general population. Secondary non-genetic ... ...

    Abstract Hyperalphalipoproteinemia (HALP) is a lipid disorder characterized by elevated plasma high-density lipoprotein cholesterol (HDL-C) levels above the 90th percentile of the distribution of HDL-C values in the general population. Secondary non-genetic factors such as drugs, pregnancy, alcohol intake, and liver diseases might induce HDL increases. Primary forms of HALP are caused by mutations in the genes coding for cholesteryl ester transfer protein (CETP), hepatic lipase (HL), apolipoprotein C-III (apo C-III), scavenger receptor class B type I (SR-BI) and endothelial lipase (EL). However, in the last decades, genome-wide association studies (GWAS) have also suggested a polygenic inheritance of hyperalphalipoproteinemia. Epidemiological studies have suggested that HDL-C is inversely correlated with cardiovascular (CV) risk, but recent Mendelian randomization data have shown a lack of atheroprotective causal effects of HDL-C. This review will focus on primary forms of HALP, the role of polygenic inheritance on HDL-C, associated risk for cardiovascular diseases and possible treatment options.
    Language English
    Publishing date 2021-06-18
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2662250-6
    ISSN 2075-1729
    ISSN 2075-1729
    DOI 10.3390/life11060581
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top